Does Pathological Stage and Nodal Involvement Influence Long Term Oncological Outcomes after CROSS Regimen for Adenocarcinoma of the Esophagogastric Junction? A Multicenter Retrospective Analysis

Does Pathological Stage and Nodal Involvement Influence Long Term Oncological Outcomes after CROSS Regimen for Adenocarcinoma of the Esophagogastric Junction? A Multicenter Retrospective Analysis

<b>Background:</b>After the results reported by the “Chemoradiotherapy for esophageal Cancer Followed by Surgery Study” (CROSS) trial, neo-adjuvant chemoradiotherapy became the standard treatment for locally advanced cancers of esophagus and gastroesophageal junction (GEJ). Excellent res...

Full description

Bibliographic Details
Main Authors: Stefano de Pascale, Paolo Parise, Michele Valmasoni, Jacopo Weindelmayer, Fabrizia Terraneo, Chiara Alessandra Cella, Simone Giacopuzzi, Andrea Cossu, Simonetta Massaron, Ugo Elmore, Stefano Merigliano, Uberto Fumagalli Romario, on behalf of the Italian Society for the Study of Esophageal Diseases (SISME)
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
gastroesophageal cancer
CROSS regimen
esophagogastric junction cancers
neoadjuvant therapy
Online Access:https://www.mdpi.com/2072-6694/13/4/666

Similar Items

Similar Items